Delivering chemotherapy at home: how much do we know?

Area of Science:

• Oncology
• Pharmaceutical Science
• Biomedical Engineering

Background:

• Ambulatory chemotherapy delivery via elastomeric pumps offers patient convenience and cost savings.
• These pumps are favored for home-based chemotherapy, minimizing disruption to patients and families.
• Existing literature suggests pump performance can be influenced by environmental factors like temperature and diluent viscosity.

Purpose of the Study:

• To evaluate the real-world performance and reliability of elastomeric infusion pumps in ambulatory chemotherapy settings.
• To identify factors contributing to infusion completion delays and their impact on patient treatment.

Main Methods:

• A two-phase study was conducted to observe and assess patients undergoing ambulatory chemotherapy.
• Performance data from elastomeric infusion pumps used in patient care were collected and analyzed.
• Factors such as temperature and diluent viscosity were considered in relation to pump performance.

Main Results:

• Experiments indicated that elastomeric pump performance varies with diluent temperature and viscosity.
• In 50% of observed ambulatory chemotherapy cases, infusion pumps did not complete infusions within the scheduled time.
• Infusion delays led to disruptions in patient treatment schedules and potential sub-therapeutic dosing.

Conclusions:

• Elastomeric pump performance in ambulatory chemotherapy is susceptible to variations in temperature and viscosity.
• A significant percentage of patients experience delayed infusions, compromising treatment efficacy and scheduling.
• Further research and improved pump technology are needed to ensure reliable ambulatory chemotherapy delivery.